CodeMap® Compliance Briefing: August 20, 2020
Editor's Welcome: Last week, the OIG published a report on Medicare expenditures for laboratory tests in 2018. The OIG performed this analysis for two reasons; one, 2018 was the first year that CMS used private payer reimbursement data to determine Medicare reimbursement amounts pursuant to PAMA; and two, PAMA requires the OIG to annually monitor and identify the top 25 tests based on Medicare spending. The report is surprising in that it demonstrates that Medicare paid $7.6 billion for lab tests in 2018, a $459 million increase over the $7.1 billion Medicare paid in 2017. Despite the fact that PAMA reduced Medicare reimbursement for more than 75% of the tests listed in the Medicare Clinical Laboratory Fe....
Sorry, access to this content requires a current subscription.
Click here for publications catalog.
CPT copyright 2021 American Medical Association. All rights reserved.
* The responsibility for the content of any "National Correct Coding Policy" included in this product is with the Centers for Medicare and Medicaid
Services and no endorsement by the AMA is intended or should be implied. The AMA disclaims responsibility for any consequences or liability attributable to or related
to any use, nonuse, or interpretation of information contained in this product.